VA Long Beach Intent to Sole Source Pylarify Radiopharmaceutical Injections

The Department of Veterans Affairs Long Beach Healthcare System issued a notice of intent to award a sole-source, firm-fixed-price delivery order for Pylarify (piflufolastat F18) radiopharmaceutical injections. The Nuclear Medicine department requires this diagnostic imaging agent for Positron Emission Tomography/Computed Tomography scans to locate prostate tumors and identify prostate-specific membrane antigen in organs, bones, and lymph nodes. The buyer intends to award the contract to Progenics Pharmaceuticals, Inc. under an existing Federal Supply Schedule contract effective from April 1, 2025, through March 31, 2030. This notice is not a request for competitive quotes or proposals. However, interested parties that are responsible, certified, and capable may submit a capabilities statement demonstrating clear and compelling evidence that they can provide the same items and that competition benefits the government. Interested vendors must email their capabilities statements to Contract Specialist Melissa Ramirez by November 3, 2026, at 10:00 AM Pacific Time.